Combo Thrombolytic Approach Fails to Reduce ICH in Stroke

The DUMAS study showed no benefit on the primary outcome of all ICH with low-dose alteplase followed by mutant pro-urokinase; but there were promising signs of a potential reduced bleeding risk.
Medscape Medical News

source https://www.medscape.com/viewarticle/983412?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?